E-Update – CB2 Insights Selected by Drug Science As Research Technology Platform For The UK’s Largest Medical Cannabis Pilot
July 22, 2019 Jamie Blundell, President & COO is pleased to provide the following update CB2 Insights, part of CGOC’s public holdings: CB2 Insights (“CB2”), part of CGOC’s public portfolio, a leading data-driven company focused on bringing Real-World Evidence driven from the point-of-care to the medical cannabis community, recently announced being selected as the…